Silva Couto, P;
Rotondi, MC;
Bersenev, A;
Hewitt, CJ;
Nienow, AW;
Verter, F;
Rafiq, QA;
(2020)
Expansion of human mesenchymal stem/stromal cells (hMSCs) in bioreactors using microcarriers: lessons learnt and what the future holds.
Biotechnology Advances
, 45
, Article 107636. 10.1016/j.biotechadv.2020.107636.
Preview |
Text
Expansion of human mesenchymal stem stromal cells v12 (sent to Qasim).pdf - Accepted Version Download (565kB) | Preview |
Abstract
Human mesenchymal stem/stromal cells (hMSCs) present a key therapeutic cellular intervention for use in cell and gene therapy (CGT) applications due to their immunomodulatory properties and multi-differentiation capability. Some of the indications where hMSCs have demonstrated pre-clinical or clinical efficacy to improve outcomes are cartilage repair, acute myocardial infarction, graft versus host disease, Crohn’s disease and arthritis. The current engineering challenge is to produce hMSCs at an affordable price and at a commercially-relevant scale whilst minimising process variability and manual, human operations. By employing bioreactors and microcarriers (due to the adherent nature of hMSCs), it is expected that production costs would decrease due to improved process monitoring and control leading to better consistency and process efficiency, and enabling economies of scale. This approach will result in off the shelf (allogeneic) hMSC-based products becoming more accessible and affordable. Importantly, cell quality, including potency, must be maintained during the bioreactor manufacturing process. This review aims to examine the various factors to be considered when developing a hMSC manufacturing process using microcarriers and bioreactors and their potential impact on the final product. As concluding remarks, gaps in the current literature and potential future areas of research are also discussed.
| Type: | Article |
|---|---|
| Title: | Expansion of human mesenchymal stem/stromal cells (hMSCs) in bioreactors using microcarriers: lessons learnt and what the future holds |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1016/j.biotechadv.2020.107636 |
| Publisher version: | https://doi.org/10.1016/j.biotechadv.2020.107636 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher's terms and conditions. |
| Keywords: | Bioprocessing, Manufacturing, Stirred-Tank Bioreactor, Mesenchymal |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > UCL BEAMS UCL > Provost and Vice Provost Offices > UCL BEAMS > Faculty of Engineering Science UCL > Provost and Vice Provost Offices > UCL BEAMS > Faculty of Engineering Science > Dept of Biochemical Engineering |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10114392 |
Archive Staff Only
 |
View Item |
